Marcin Urbaszek
Analyst · Credit Suisse. Please go ahead
Thank you, Steve. Good morning, everyone, and thank you for joining us today. Yesterday afternoon, we reported a third quarter GAAP net loss of $29.1 million or $0.56 per basic share, which reflects a provision for credit losses of $35.4 million or $0.68 per basic share. Distributable earnings for the third quarter were $8.7 million or $0.17 per basic share and exclude the provision expense. Our Q3 book value declined by about $0.77 per share to $15.24 and was mainly affected by the increase in CECL reserves, which at quarter end totaled $85.6 million or $1.63 per common share and represented about 218 basis points of our total loan commitments. Away from the credit reserve build, our third quarter results were also affected by a $3.6 million or $0.07 per basic share decline in net interest income, driven by two factors: one, our nonaccrual loans; and two, loans with high-rate floors that did not benefit from a full quarter of higher interest rates. As of September, the benchmark rates were above all of our interest rate floors, and our portfolio is now 100% rate sensitive, excluding the nonaccruals. During the third quarter, we downgraded two office loans to a risk rating of five and place them on nonaccrual status. At September 30, we had four loans with a total principal balance of about $330 million that were on nonaccrual status. We estimate that these assets impacted our interest income by about $4 million or about $0.08 per share during the third quarter. However, as Steve just discussed, we successfully resolved a nonaccrual loan in late October, that $114 million retail asset in California, resulting in a new earning asset and releasing additional capital. During the third quarter, we increased our CECL reserves to $85.6 million from $50.1 million at June 30. About $30 million of the increase was related to our four loans with risk ratings of 5. At quarter end, the aggregate allowance allocated to these loans totaled about $50 million. As just mentioned, one of these loans was resolved in the fourth quarter. The main driver of our Q3 CECL reserve increase relates to deteriorating market conditions, reduced liquidity in the capital markets, delays in execution of business plans and our overall conservative view of the macro environment. Turning to our capitalization and liquidity. Our total debt-to-equity ratio at September 30 modestly decreased to 2.6x from 2.7x at the end of June, mainly due to loan repayments and deleveraging of certain assets. We ended the third quarter with about $168 million in unrestricted cash, plus another $45 million in restricted cash, mostly in our CLOs. Since quarter end, we contributed certain loan assets into our CLOs, releasing capital, realized additional prepayments. And as of November 7, we had over $220 million in unrestricted cash on the balance sheet. We anticipate satisfying our convertible bond maturity in December with cash on hand, and we continue to work on further improving our liquidity and developing additional financing sources. To that point, during the third quarter, we closed on a new $100 million facility, providing us loan level financing on a non-mark-to-market basis, allowing for additional funding flexibility within our capital structure. Our risk-weighted five loans have been meaningfully delevered over time, and two of them are financed on a non-mark-to-market basis, and we anticipate that the remaining nonaccruals will also be financed on a non-mark-to-market basis in the near term. Thank you again for joining us today. And with that, we would like to open the call for questions.